The ‘special’ Yorkshire firm using stem cell technology to cure deafness which could save the country billions.

Published by Russell Schofield-Bezer on

Sheffield’s Rinri Therapeutics is one of many ‘world-class’ firms in the North to benefit from Northern Gritstone’s new investment programme. Read more here.

Categories: Industry NewsNorthern Gritstone News

Related Posts

Investment

Northern Gritstone backs spin out of Imperagen, a University of Manchester Life Science Business

Imperagen has developed a unique technology to accelerate the design, optimisation, and validation of novel enzymes for large molecular drug discovery. Northern Gritstone, along with IQ Capital, has led a £3.5 million Seed Round to Read more…

Industry News

Northern Gritstone secures first close of £215m ahead of making its first investments

Northern Gritstone, the new investment business focused on university spin-outs in the north of England, today announces a first close of £215m having seen strong interest from investors in its proposition.   The company, chaired Read more…

Northern Gritstone News

How Northern Gritstone is hoping to bridge the North-South research funding gap.

Duncan Johnson, chief executive at Northern Gritstone, discusses how there is “a level playing field of science and a totally and utterly uneven level playing field of funding”. Listen here.